NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Hanwha Aerospace, KATECH to collaborate on hydrogen fuel cell
South Korea's Hanwha Aerospace Co. announced on Monday it signed a memorandum of understanding (MOU) with the Korea Automotive Technology Institute ...
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
HD KSOE to invest $48 mn in European fuel cell company
HD Korea Shipbuilding & Offshore Engineering (KSOE) announced on Wednesday that it plans to invest 45 million euros ($47.7 million) in the Europ...
Hyundai, Iveco solidify partnership with E-WAY H2 hydrogen fuel cell bus
South Korea’s top automaker Hyundai Motor Co. and Italian truck maker Iveco Group N.V. have consolidated their business partnership through th...
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Pulmuone, BlueNalu team up for cell-cultured seafood
South Korean food company Pulmuone revealed plans on Thursday to boost its strategic partnership with US-based seafood startup BlueNalu, focusing on...
SK becomes top shareholder of US contract drug maker CBM
SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...
Battery cell prices plummet amid supply glut in China, weak EV demand
The competition among automakers to cut prices of electric vehicles is expected to intensify with battery cell prices falling at a fast pace due to ...
Hyundai NEXO retains fuel cell EV leadership; Toyota Mirai follows fast
South Korea’s top automaker Hyundai Motor Co. retained its leadership in the hydrogen fuel cell electric vehicle (FCEV) market in the January-...
Solus aims to mass-produce copper foil in Canada from 2026
Solus Advanced Materials Co., a South Korean copper foil supplier to Tesla Inc., on Tuesday broke ground on its third overseas plant in Quebec, Cana...
China, beneficiary of Korea’s surging EV cell material exports
South Korea’s exports of cathodes for secondary batteries are surging with the booming electric vehicle industry, but the country’s trad...
SK Ecoplant to supply fuel cells to Singapore data center
South Korea's SK Ecoplant will supply solid oxide fuel cells (SOFC) for the power supply system of a data center to be built in Singapore by GDS, Ch...
Hanwha Q Cells brings forward US solar module production
Hanwha Q Cells Co., a solar power unit of South Korea’s chemicals-to-defense conglomerate Hanwha Group, brought forward operations of a US pla...
SK On unveils new material to improve EV battery capacity
SK On Co., the world’s fifth-largest electric vehicle cell maker, has unveiled a new material to improve its competitiveness in the solid-stat...
S.Korean battery trio face union risk in US after Ultium Cells’ wage deal
South Korean electric vehicle battery majors’ plan to run more than 10 EV battery manufacturing plants in the US may hit a snag due to the loo...
Young Poong, Lotte Global Logistics to form battery recycling supply chain
South Korea’s non-ferrous metal company Young Poong Co. has teamed up with Lotte Global Logistics Co. to form a supply chain system for recycl...
Hanwha Q Cells expects windfall gain from Chinese rivals’ woes
Hanwha Q Cells Co., a solar power unit of South Korean conglomerate Hanwha Group, is expected to enjoy a windfall gain from the US government’...
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
SK On to expand domestic battery cell plant for $1.1 bn
SK On Co., a South Korean rechargeable battery maker, will make its largest-ever domestic facility investment of 1.5 trillion won ($1.1 billion) to ...
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
SK Nexilis to sell copper foil to German battery maker Varta
South Korea’s SK Nexilis Co. is set to supply copper foil, core materials for electric vehicle cells, to German battery maker Varta AG, expand...
Korea’s STX to build joint Indonesia nickel plant for EV cells
South Korea’s trading company STX Corp. is set to build a nickel plant with an Indonesian company in the Southeast Asian country to expand its...
Gencurix joins US gov't Cancer Moonshot project
South Korean cancer molecular diagnostics company Gencurix Inc. announced on Monday that it joins US President Joe Biden's cancer-conquering project...
SKC, Toyota Tsusho tie up for N.America battery materials
SKC Ltd., a South Korean chemicals maker, has joined hands with the trading unit of Japanese top automaker Toyota Group for the electric vehicle bat...
Doosan secures $392 mn in cumulative PFC orders
South Korea's Doosan Corp. announced on Monday that it has accumulated 500 billion won ($392 million) in orders for its patterned flat cable (PFC), ...
Solidigm launches world's largest capacity SSD for data centers
Solidigm, the NAND flash-making subsidiary of South Korea's semiconductor titan SK Hynix Inc., on Monday announced the release of its solid state dr...
Hanwha Q Cells pursues next-gen energy solutions other than solar
Lee Koo-yung, CEO of the solar power unit Qcells Division (Hanwha Q Cells) of South Korea's Hanwha Solutions Corp., on Monday said, "We will go beyo...
SK Biopharm eyes Asia's No.1 spot in radioactive drug market
South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...
GI Innovation seeks to license allergy therapy to Japan in 2023
South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...
